Balancing act: optimizing blue light for melanogenesis while minimizing cellular damage in primary human skin cells.

Augustin C Barolet1,2,3,4, Brice Magne1,2,4, Karel Ferland1,2,4

  • 1Regenerative Medicine Division, CHU de Quebec - Université Laval Research Centre, Quebec City, QC, Canada.

Frontiers in Physiology
|January 24, 2025
PubMed
Summary

Moderate blue light (10 mW/cm², 15 J/cm²) stimulates melanogenesis and preserves skin cell activity. This finding offers a safe, effective approach for blue light therapies targeting pigmentation disorders.